Industrial - Distribution
Compare Stocks
5 / 10Stock Comparison
BRIA vs CAMT vs ONTO vs ACMR vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
BRIA vs CAMT vs ONTO vs ACMR vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Distribution | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $46M | $7.18B | $13.63B | $3.92B | $2.47B |
| Revenue (TTM) | $64M | $472M | $1.03B | $901M | $959M |
| Net Income (TTM) | $3M | $134M | $106M | $94M | $-51M |
| Gross Margin | 16.2% | 50.3% | 48.8% | 44.4% | 11.3% |
| Operating Margin | 6.3% | 26.6% | 10.0% | 12.1% | -3.8% |
| Forward P/E | — | 55.5x | 38.7x | 29.7x | 62.2x |
| Total Debt | $2M | $207M | $17M | $303M | $186M |
| Cash & Equiv. | $8M | $126M | $346M | $766M | $98M |
BRIA vs CAMT vs ONTO vs ACMR vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| Brillia Inc (BRIA) | 100 | 46.4 | -53.6% |
| Camtek Ltd. (CAMT) | 100 | 259.2 | +159.2% |
| Onto Innovation Inc. (ONTO) | 100 | 166.9 | +66.9% |
| ACM Research, Inc. (ACMR) | 100 | 344.4 | +244.4% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 217.4 | +117.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRIA vs CAMT vs ONTO vs ACMR vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRIA is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 0.64 vs ICHR's 3.93, lower leverage
CAMT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.99, yield 0.6%
- Rev growth 36.1%, EPS growth 50.3%, 3Y rev CAGR 16.8%
- 106.7% 10Y total return vs ACMR's 30.7%
- Beta 1.99, yield 0.6%, current ratio 5.00x
ONTO is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 2.66, Low D/E 0.8%, current ratio 5.79x
ACMR ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.84 vs CAMT's 1.59
- Lower P/E (29.7x vs 62.2x)
ICHR is the clearest fit if your priority is momentum.
- +329.1% vs BRIA's -27.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.1% revenue growth vs ONTO's 1.8% | |
| Value | Lower P/E (29.7x vs 62.2x) | |
| Quality / Margins | 28.4% margin vs ICHR's -5.3% | |
| Stability / Safety | Beta 0.64 vs ICHR's 3.93, lower leverage | |
| Dividends | 0.6% yield, 2-year raise streak, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +329.1% vs BRIA's -27.0% | |
| Efficiency (ROA) | 13.7% ROA vs ICHR's -5.2%, ROIC 13.7% vs -3.9% |
BRIA vs CAMT vs ONTO vs ACMR vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
BRIA vs CAMT vs ONTO vs ACMR vs ICHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAMT leads in 2 of 6 categories
ACMR leads 1 • BRIA leads 1 • ONTO leads 0 • ICHR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CAMT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ONTO is the larger business by revenue, generating $1.0B annually — 16.0x BRIA's $64M. CAMT is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to ICHR's -5.3%. On growth, CAMT holds the edge at +20.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $64M | $472M | $1.0B | $901M | $959M |
| EBITDAEarnings before interest/tax | — | $161M | $158M | $126M | -$11M |
| Net IncomeAfter-tax profit | — | $134M | $106M | $94M | -$51M |
| Free Cash FlowCash after capex | — | $0 | $239M | -$69M | -$17M |
| Gross MarginGross profit ÷ Revenue | +16.2% | +50.3% | +48.8% | +44.4% | +11.3% |
| Operating MarginEBIT ÷ Revenue | +6.3% | +26.6% | +10.0% | +12.1% | -3.8% |
| Net MarginNet income ÷ Revenue | +4.4% | +28.4% | +10.3% | +10.4% | -5.3% |
| FCF MarginFCF ÷ Revenue | -7.1% | +26.1% | +23.2% | -7.6% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +20.2% | +9.5% | +9.4% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +21.1% | -48.5% | -76.1% | +46.2% |
Valuation Metrics
ACMR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 56% valuation discount to ONTO's 98.6x P/E. Adjusting for growth (PEG ratio), ACMR offers better value at 1.22x vs ONTO's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $46M | $7.2B | $13.6B | $3.9B | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $40M | $7.3B | $13.3B | $3.5B | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | — | 79.79x | 98.57x | 43.21x | -46.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 55.49x | 38.74x | 29.68x | 62.25x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.28x | 2.85x | 1.22x | — |
| EV / EBITDAEnterprise value multiple | 8.79x | — | 68.79x | 27.49x | — |
| Price / SalesMarket cap ÷ Revenue | 0.71x | — | 13.56x | 4.35x | 2.61x |
| Price / BookPrice ÷ Book value/share | — | 17.36x | 6.43x | 2.06x | 3.67x |
| Price / FCFMarket cap ÷ FCF | — | — | 45.47x | — | — |
Profitability & Efficiency
BRIA leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BRIA delivers a 21.5% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-8 for ICHR. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CAMT's 0.38x. On the Piotroski fundamental quality scale (0–9), CAMT scores 7/9 vs ACMR's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +21.5% | +21.4% | +5.2% | +6.1% | -7.5% |
| ROA (TTM)Return on assets | +10.1% | +13.7% | +4.7% | +3.9% | -5.2% |
| ROICReturn on invested capital | +44.1% | +13.7% | +5.7% | +7.0% | -3.9% |
| ROCEReturn on capital employed | +29.5% | +14.8% | +6.5% | +6.6% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 4 | 2 | 3 |
| Debt / EquityFinancial leverage | 0.09x | 0.38x | 0.01x | 0.16x | 0.28x |
| Net DebtTotal debt minus cash | -$6M | $81M | -$329M | -$463M | $87M |
| Cash & Equiv.Liquid assets | $8M | $126M | $346M | $766M | $98M |
| Total DebtShort + long-term debt | $2M | $207M | $17M | $303M | $186M |
| Interest CoverageEBIT ÷ Interest expense | 8.12x | 4356.62x | — | 20.44x | -5.97x |
Total Returns (Dividends Reinvested)
CAMT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAMT five years ago would be worth $62,673 today (with dividends reinvested), compared to $4,908 for BRIA. Over the past 12 months, ICHR leads with a +329.1% total return vs BRIA's -27.0%. The 3-year compound annual growth rate (CAGR) favors CAMT at 91.6% vs BRIA's -21.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +5.8% | +67.2% | +65.2% | +31.9% | +249.0% |
| 1-Year ReturnPast 12 months | -27.0% | +177.5% | +118.9% | +195.6% | +329.1% |
| 3-Year ReturnCumulative with dividends | -50.9% | +603.4% | +218.0% | +487.9% | +151.1% |
| 5-Year ReturnCumulative with dividends | -50.9% | +526.7% | +312.6% | +133.4% | +28.9% |
| 10-Year ReturnCumulative with dividends | -50.9% | +10665.7% | +1431.7% | +3065.8% | +629.1% |
| CAGR (3Y)Annualised 3-year return | -21.1% | +91.6% | +47.1% | +80.5% | +35.9% |
Risk & Volatility
Evenly matched — BRIA and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
BRIA is the less volatile stock with a 0.64 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs BRIA's 37.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 1.99x | 2.66x | 3.24x | 3.93x |
| 52-Week HighHighest price in past year | $4.95 | $210.20 | $315.86 | $71.65 | $72.87 |
| 52-Week LowLowest price in past year | $1.41 | $62.88 | $85.88 | $19.26 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +37.0% | +91.9% | +86.8% | +82.6% | +97.7% |
| RSI (14)Momentum oscillator 0–100 | 50.3 | 63.0 | 61.0 | 60.7 | 66.9 |
| Avg Volume (50D)Average daily shares traded | 4K | 401K | 832K | 1.2M | 795K |
Analyst Outlook
Evenly matched — CAMT and ACMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CAMT as "Buy", ONTO as "Buy", ACMR as "Buy", ICHR as "Buy". Consensus price targets imply 12.5% upside for ONTO (target: $308) vs -32.4% for ACMR (target: $40). For income investors, CAMT offers the higher dividend yield at 0.63% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $165.60 | $308.33 | $40.00 | $49.80 |
| # AnalystsCovering analysts | — | 13 | 11 | 10 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | — | +0.2% | — |
| Dividend StreakConsecutive years of raises | 0 | 2 | — | 3 | 1 |
| Dividend / ShareAnnual DPS | — | $1.22 | — | $0.11 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | — | +0.6% | +0.2% | 0.0% |
CAMT leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ACMR leads in 1 (Valuation Metrics). 2 tied.
BRIA vs CAMT vs ONTO vs ACMR vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRIA or CAMT or ONTO or ACMR or ICHR a better buy right now?
For growth investors, Camtek Ltd.
(CAMT) is the stronger pick with 36. 1% revenue growth year-over-year, versus 1. 8% for Onto Innovation Inc. (ONTO). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate Camtek Ltd. (CAMT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRIA or CAMT or ONTO or ACMR or ICHR?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus Onto Innovation Inc. at 98. 6x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ACM Research, Inc. wins at 0. 84x versus Camtek Ltd. 's 1. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BRIA or CAMT or ONTO or ACMR or ICHR?
Over the past 5 years, Camtek Ltd.
(CAMT) delivered a total return of +526. 7%, compared to -50. 9% for Brillia Inc (BRIA). Over 10 years, the gap is even starker: CAMT returned +106. 7% versus BRIA's -50. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRIA or CAMT or ONTO or ACMR or ICHR?
By beta (market sensitivity over 5 years), Brillia Inc (BRIA) is the lower-risk stock at 0.
64β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 509% more volatile than BRIA relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 38% for Camtek Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRIA or CAMT or ONTO or ACMR or ICHR?
By revenue growth (latest reported year), Camtek Ltd.
(CAMT) is pulling ahead at 36. 1% versus 1. 8% for Onto Innovation Inc. (ONTO). On earnings-per-share growth, the picture is similar: Camtek Ltd. grew EPS 50. 3% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRIA or CAMT or ONTO or ACMR or ICHR?
Camtek Ltd.
(CAMT) is the more profitable company, earning 27. 6% net margin versus -5. 6% for Ichor Holdings, Ltd. — meaning it keeps 27. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAMT leads at 25. 2% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRIA or CAMT or ONTO or ACMR or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ACM Research, Inc. (ACMR) is the more undervalued stock at a PEG of 0. 84x versus Camtek Ltd. 's 1. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACM Research, Inc. (ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 12. 5% to $308. 33.
08Which pays a better dividend — BRIA or CAMT or ONTO or ACMR or ICHR?
In this comparison, CAMT (0.
6% yield), ACMR (0. 2% yield) pay a dividend. BRIA, ONTO, ICHR do not pay a meaningful dividend and should not be held primarily for income.
09Is BRIA or CAMT or ONTO or ACMR or ICHR better for a retirement portfolio?
For long-horizon retirement investors, Brillia Inc (BRIA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
64)). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BRIA: -50. 9%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRIA and CAMT and ONTO and ACMR and ICHR?
These companies operate in different sectors (BRIA (Industrials) and CAMT (Technology) and ONTO (Technology) and ACMR (Technology) and ICHR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRIA is a small-cap high-growth stock; CAMT is a small-cap high-growth stock; ONTO is a mid-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock. CAMT pays a dividend while BRIA, ONTO, ACMR, ICHR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.